Target intelligence / Profile preview

Iron-responsive element in the 5'-untranslated region of TARDBP mRNA (TARDBP 5'-UTR IRE)

Target
TARDBP 5'-UTR IRE
Molecular classification
RNA regulatory element, Cis-regulatory element, Non-coding RNA structure
01

Overview

The iron-responsive element (IRE) in the 5'-untranslated region (UTR) of the TARDBP mRNA is a conserved RNA stem-loop structure that serves as a critical regulator of TDP-43 protein synthesis. This element functions by binding to iron regulatory proteins (IRPs) under conditions of low cellular iron, which sterically blocks the assembly of the translation initiation complex and suppresses the production of TDP-43. In neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD), the pathological accumulation and aggregation of TDP-43 are central to disease progression. Therapeutic targeting of this IRE aims to modulate TDP-43 levels at the translational level rather than the transcriptional level. Small molecules like Buntanetap (Posiphen) are being investigated for their ability to bind these IRE structures and reduce the translation of neurotoxic proteins, including TDP-43, thereby potentially slowing neurodegeneration. This approach represents a novel strategy to restore proteostasis by leveraging the cell's endogenous iron-sensing machinery.

Other names
TDP-43 IRETARDBP IREIron-responsive element of TDP-435'-UTR IRE of TARDBPTDP-43 mRNA iron-responsive element
02

Mechanism of action

Small molecule binding to the IRE structure in the 5'-UTR of the mRNA to sterically hinder the recruitment of the ribosomal translation initiation complex, thereby suppressing the translation of the TARDBP mRNA into TDP-43 protein.

03

Biological functions

Translational regulationIron homeostasisPost-transcriptional regulationmRNA stability
04

Disease associations

Amyotrophic lateral sclerosisFrontotemporal dementiaNeurodegenerative diseaseLimbic-predominant age-related TDP-43 encephalopathy (LATE)
05

Safety considerations

Potential off-target suppression of other IRE-containing mRNAs such as Ferritin or ALAS2Systemic iron metabolism disruptionRisk of excessive reduction of physiological TDP-43 required for normal RNA processingPotential for unintended effects on erythropoiesis
06

Interacting drugs

Buntanetap (Posiphen)
07

Biomarkers

TDP-43 protein levels in cerebrospinal fluidTDP-43 protein levels in plasmaIron regulatory protein (IRP) binding affinityIntracellular iron concentration

Beyond the preview

Go deeper on Iron-responsive element in the 5'-untranslated region of TARDBP mRNA (TARDBP 5'-UTR IRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron-responsive element in the 5'-untranslated region of TARDBP mRNA (TARDBP 5'-UTR IRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call